Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Is ETI safe for the liver? A two-year study from Denmark offers reassuring results.

Is ETI safe for the liver? A two-year study from Denmark offers reassuring results.

Resource Type

CF Research News

Authors

Christine Højte, Mette Frahm Olsen, Daniel Faurholt-Jepsen, Marianne Hørby Jørgensen, Tacjana Pressler, Christian Leo-Hansen, Thomas Bryrup, Majbritt Jeppesen, Hanne Vebert Olesen, Janne Petersen, Terese L. Katzenstein, Bibi Uhre Nielsen, Marianne Skov, a

References

doi: 10.1016/j.jcf.2025.08.008

Document

File JCF-D-25-00145R2_FINAL_Hojte Dahl_25082025.docx [1]

Keywords

Elexacaftor/tezacaftor/ivacaftor [2]
Long-term changes [3]
Cystic fibrosis liver disease [4]
Hepatotoxicity [5]

Date

Monday, August 4, 2025

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/eti-safe-liver-two-year-study-denmark-offers-reassuring-results

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-25-00145R2_FINAL_Hojte%20Dahl_25082025.docx [2] https://www.ecfs.eu/research-article-keywords/elexacaftortezacaftorivacaftor [3] https://www.ecfs.eu/research-article-keywords/long-term-changes [4] https://www.ecfs.eu/research-article-keywords/cystic-fibrosis-liver-disease [5] https://www.ecfs.eu/research-article-keywords/hepatotoxicity [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines